TT-10–loaded nanoparticles promote cardiomyocyte proliferation and cardiac repair in a mouse model of myocardial infarction

The meager regenerative capacity of adult mammalian hearts appears to be driven by the proliferation of endogenous cardiomyocytes; thus, strategies targeting mechanisms of cardiomyocyte cell cycle regulation, such as the Hippo/Yes-associated protein (Hippo/Yap) pathway, could lead to the development...

Full description

Bibliographic Details
Main Authors: Wangping Chen, Danielle Pretorius, Yang Zhou, Yuji Nakada, Jinfu Yang, Jianyi Zhang
Format: Article
Language:English
Published: American Society for Clinical investigation 2021-10-01
Series:JCI Insight
Subjects:
Online Access:https://doi.org/10.1172/jci.insight.151987
_version_ 1811226967220944896
author Wangping Chen
Danielle Pretorius
Yang Zhou
Yuji Nakada
Jinfu Yang
Jianyi Zhang
author_facet Wangping Chen
Danielle Pretorius
Yang Zhou
Yuji Nakada
Jinfu Yang
Jianyi Zhang
author_sort Wangping Chen
collection DOAJ
description The meager regenerative capacity of adult mammalian hearts appears to be driven by the proliferation of endogenous cardiomyocytes; thus, strategies targeting mechanisms of cardiomyocyte cell cycle regulation, such as the Hippo/Yes-associated protein (Hippo/Yap) pathway, could lead to the development of promising therapies for heart disease. The pharmacological product TT-10 increases cardiomyocyte proliferation by upregulating nuclear Yap levels. When intraperitoneal injections of TT-10 were administered to infarcted mouse hearts, the treatment promoted cardiomyocyte proliferation and was associated with declines in infarct size 1 week after administration, but cardiac function worsened at later time points. Here, we investigated whether encapsulating TT-10 into poly-lactic-co-glycolic acid nanoparticles (NPs) before administration could extend the duration of TT-10 delivery and improve the potency of TT-10 for myocardial repair. TT-10 was released from the TT-10–loaded NPs for up to 4 weeks in vitro, and intramyocardial injections of TT-10–delivered NPs stably improved cardiac function from week 1 to week 4 after administration to infarcted mouse hearts. TT-10–delivered NP treatment was also associated with significantly smaller infarcts at week 4, with increases in cardiomyocyte proliferation and nuclear Yap abundance and with declines in cardiomyocyte apoptosis. Thus, NP-mediated delivery appears to enhance both the potency and durability of TT-10 treatment for myocardial repair.
first_indexed 2024-04-12T09:33:28Z
format Article
id doaj.art-5757b97997e84a04b40e90b1cc42617f
institution Directory Open Access Journal
issn 2379-3708
language English
last_indexed 2024-04-12T09:33:28Z
publishDate 2021-10-01
publisher American Society for Clinical investigation
record_format Article
series JCI Insight
spelling doaj.art-5757b97997e84a04b40e90b1cc42617f2022-12-22T03:38:17ZengAmerican Society for Clinical investigationJCI Insight2379-37082021-10-01620TT-10–loaded nanoparticles promote cardiomyocyte proliferation and cardiac repair in a mouse model of myocardial infarctionWangping ChenDanielle PretoriusYang ZhouYuji NakadaJinfu YangJianyi ZhangThe meager regenerative capacity of adult mammalian hearts appears to be driven by the proliferation of endogenous cardiomyocytes; thus, strategies targeting mechanisms of cardiomyocyte cell cycle regulation, such as the Hippo/Yes-associated protein (Hippo/Yap) pathway, could lead to the development of promising therapies for heart disease. The pharmacological product TT-10 increases cardiomyocyte proliferation by upregulating nuclear Yap levels. When intraperitoneal injections of TT-10 were administered to infarcted mouse hearts, the treatment promoted cardiomyocyte proliferation and was associated with declines in infarct size 1 week after administration, but cardiac function worsened at later time points. Here, we investigated whether encapsulating TT-10 into poly-lactic-co-glycolic acid nanoparticles (NPs) before administration could extend the duration of TT-10 delivery and improve the potency of TT-10 for myocardial repair. TT-10 was released from the TT-10–loaded NPs for up to 4 weeks in vitro, and intramyocardial injections of TT-10–delivered NPs stably improved cardiac function from week 1 to week 4 after administration to infarcted mouse hearts. TT-10–delivered NP treatment was also associated with significantly smaller infarcts at week 4, with increases in cardiomyocyte proliferation and nuclear Yap abundance and with declines in cardiomyocyte apoptosis. Thus, NP-mediated delivery appears to enhance both the potency and durability of TT-10 treatment for myocardial repair.https://doi.org/10.1172/jci.insight.151987CardiologyTherapeutics
spellingShingle Wangping Chen
Danielle Pretorius
Yang Zhou
Yuji Nakada
Jinfu Yang
Jianyi Zhang
TT-10–loaded nanoparticles promote cardiomyocyte proliferation and cardiac repair in a mouse model of myocardial infarction
JCI Insight
Cardiology
Therapeutics
title TT-10–loaded nanoparticles promote cardiomyocyte proliferation and cardiac repair in a mouse model of myocardial infarction
title_full TT-10–loaded nanoparticles promote cardiomyocyte proliferation and cardiac repair in a mouse model of myocardial infarction
title_fullStr TT-10–loaded nanoparticles promote cardiomyocyte proliferation and cardiac repair in a mouse model of myocardial infarction
title_full_unstemmed TT-10–loaded nanoparticles promote cardiomyocyte proliferation and cardiac repair in a mouse model of myocardial infarction
title_short TT-10–loaded nanoparticles promote cardiomyocyte proliferation and cardiac repair in a mouse model of myocardial infarction
title_sort tt 10 loaded nanoparticles promote cardiomyocyte proliferation and cardiac repair in a mouse model of myocardial infarction
topic Cardiology
Therapeutics
url https://doi.org/10.1172/jci.insight.151987
work_keys_str_mv AT wangpingchen tt10loadednanoparticlespromotecardiomyocyteproliferationandcardiacrepairinamousemodelofmyocardialinfarction
AT daniellepretorius tt10loadednanoparticlespromotecardiomyocyteproliferationandcardiacrepairinamousemodelofmyocardialinfarction
AT yangzhou tt10loadednanoparticlespromotecardiomyocyteproliferationandcardiacrepairinamousemodelofmyocardialinfarction
AT yujinakada tt10loadednanoparticlespromotecardiomyocyteproliferationandcardiacrepairinamousemodelofmyocardialinfarction
AT jinfuyang tt10loadednanoparticlespromotecardiomyocyteproliferationandcardiacrepairinamousemodelofmyocardialinfarction
AT jianyizhang tt10loadednanoparticlespromotecardiomyocyteproliferationandcardiacrepairinamousemodelofmyocardialinfarction